Comparison of Cardiac Index and Stroke-volume-index Measured by Pulmonary Artery Catheter, FloTrac® and Argos® in Cardiac Surgery Patients.
Launched by KARLSBURG HOSPITAL · Apr 5, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well different devices measure the heart's performance in patients who have just undergone heart surgery. Specifically, it compares three methods: a pulmonary artery catheter, a FloTrac device, and an Argos monitor. These devices help doctors understand how well the heart is pumping blood, which is crucial for managing patients after surgery. The study will take place in the operating room and in the intensive care unit (ICU) for both patients on ventilators and those breathing on their own.
To be eligible for this trial, patients must have had heart surgery and have a pulmonary artery catheter placed. However, those who are unstable or unable to give consent will not be included. Participants can expect to have their heart performance monitored using these different devices during their recovery. This research may help improve how doctors monitor heart health after surgery, making it safer and more effective for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient after cardiac surgery with pulmonary artery catheter
- Exclusion Criteria:
- • Hemodynamic instability, no consent
About Karlsburg Hospital
Karlsburg Hospital is a distinguished healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on multidisciplinary collaboration, the hospital is committed to conducting high-quality studies that adhere to rigorous ethical standards and regulatory guidelines. By leveraging state-of-the-art facilities and a team of experienced healthcare professionals, Karlsburg Hospital aims to contribute valuable insights to the medical community, ultimately enhancing treatment options and fostering the development of new therapies for a variety of health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karlsburg, , Germany
Patients applied
Trial Officials
Matthias Heringlake
Principal Investigator
Head of Department of Anesthesiology and intensive care, Karlsburg Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported